KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Humana (HUM) EBITDA (2016 - 2025)

Historic EBITDA for Humana (HUM) over the last 17 years, with Q3 2025 value amounting to $591.0 million.

  • Humana's EBITDA fell 3817.99% to $591.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year increase of 330.51%. This contributed to the annual value of $3.5 billion for FY2024, which is 2864.49% down from last year.
  • Humana's EBITDA amounted to $591.0 million in Q3 2025, which was down 3817.99% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Humana's EBITDA peaked at $2.2 billion during Q1 2025, and registered a low of -$317.0 million during Q4 2024.
  • For the 5-year period, Humana's EBITDA averaged around $1.1 billion, with its median value being $1.4 billion (2024).
  • Its EBITDA has fluctuated over the past 5 years, first surged by 21201.92% in 2021, then tumbled by 15158.73% in 2024.
  • Quarter analysis of 5 years shows Humana's EBITDA stood at $233.0 million in 2021, then soared by 36.48% to $318.0 million in 2022, then crashed by 139.62% to -$126.0 million in 2023, then crashed by 151.59% to -$317.0 million in 2024, then soared by 286.44% to $591.0 million in 2025.
  • Its last three reported values are $591.0 million in Q3 2025, $1.3 billion for Q2 2025, and $2.2 billion during Q1 2025.